Sobi, Inc.
- Partner Level
- Platinum
- Website
- Visit Site
At Sobi North America, we are committed to delivering treatment options for patients with Immune thrombocytopenia (ITP), a rare autoimmune disease affecting platelet production and characterized by fatigue, bruising and bleeding. Today, there is increased awareness of the available treatment options, and better life may be possible for people living with ITP.Our portfolio also addresses cytopenic myelofibrosis, a rare blood disease characterized by scarring of the bone marrow, as well as disruption of the normal production of blood cells. We are dedicated to delivering the promise of a better life for those living with rare and severe blood diseases. https://www.sobi.com/usa/en
Patient Support
Report Adverse Reactions or Product Complaints – Patient safety is a priority for Sobi. We are committed to collect, analyze and react upon any new information about the benefits and risks of our Products. If you have information about a side effect or adverse reaction associated with any of our products, please let us know via drugsafety@sobi.com.
